Drug · DIN 02409402
RIZATRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 23, 2013.
- Drug Identification Number (DIN)
- 02409402
- Company (DIN owner)
- Jubilant Generics LimitedNoida, Uttar Pradesh, India
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 23, 2013: NOC 14580Abbreviated New Drug Submission (ANDS)
Other DINs named RIZATRIPTAN
- DIN 02516756 · Marketed
- DIN 02409399 · Approved
- DIN 02516721 · Approved